Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.
about
Toxicity management of immunotherapy for patients with metastatic melanomaImmune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know.PD-1 inhibitors increase the incidence and risk of pneumonitis in cancer patients in a dose-independent manner: a meta-analysis.The safety of nivolumab for the treatment of advanced non-small cell lung cancer.Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer.Immune checkpoint blockade as a potential therapeutic target in non-small cell lung cancer.Case report of nivolumab-related pneumonitis.Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.Concurrence of nivolumab-induced interstitial lung disease and cancer invasion.Do hospitals need oncological critical care units?Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management.PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course.Melanoma patient response to nivolumab treatment for metastatic lung lesions: Multi-OMICS analysis in Project HOPE.Ipilimumab and early signs of pulmonary toxicity in patients with metastastic melanoma: a prospective observational study.Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care.Best Practices in Treatment Selection for Patients With Advanced NSCLC.PD-1 inhibitor-related pneumonitis in lymphoma patients treated with single-agent pembrolizumab therapy.Pulmonary side effects of nivolumab in a patient treated for gynecological malignancy.Immunotherapy-induced pneumonitis: cases report.A case of interstitial lung disease with alveolar hemorrhage induced by pembrolizumab
P2860
Q26738662-242CDEE7-D97B-488B-8D46-2163EA0A62C7Q37589557-8DBB73F8-3EFF-4A0F-8A8C-3F55B70195CCQ37685959-AADE3ABE-BA1C-415F-978C-2FD0F3F466D6Q38788124-59F8E387-3349-4E38-BAD3-9625DA73CF4AQ38870763-E2219192-4EA1-474B-9D8B-8E76EF7C1DA1Q38899873-FD880EFA-F4E7-4C79-8232-BA31CBC27795Q40064825-192A7342-F39C-4676-BA78-25F2B930E35BQ40534742-CE3B69B3-4E4D-452F-A0D3-7A757098EDF7Q41358589-AF963DC2-5823-442F-B954-22EB88E80F6EQ42362328-E7F98AAE-E970-4E02-8C97-BE51CF89754EQ45026631-6BF34ED2-2744-486C-AD84-BD7F2F5BD89FQ46320590-12BE95D0-17A2-489D-9534-2F901AAFA691Q47577369-AD9CF11F-36BA-452A-B406-48CB527F8D02Q47752171-F1FCA426-7FD2-491E-AA9C-2169CE9636B7Q50133191-5827AB2F-89B2-4DBB-9A9B-13AED6460446Q52814108-2B7DA0CA-7648-4594-9144-3AB458E9D0A4Q54256109-7AA9C657-2477-4D06-9F37-73682FE1FDEFQ55261260-24C9C04C-D1B9-4DD1-9E39-26357DBB8AB8Q55422184-D9D2207D-84B0-40B9-B709-646800700200Q57074555-F2809D2A-7627-4E25-802E-77CD3805F301
P2860
Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.
@ast
Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.
@en
type
label
Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.
@ast
Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.
@en
prefLabel
Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.
@ast
Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.
@en
P2093
P2860
P1476
Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.
@en
P2093
Curtis R Chong
Emily S Chambers
F Stephen Hodi
Hiroto Hatabu
J Paul Marcoux
Mark M Awad
Mizuki Nishino
Nikhil H Ramaiya
Stacy W Gray
P2860
P304
P356
10.1158/2326-6066.CIR-15-0267
P50
P577
2016-02-10T00:00:00Z